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Across germ layer barriers
Thymic epithelial cells (TECs) function in the generation of self-
tolerant thymocytes via the autoimmune regulator Aire. Some 
cells in the thymic medulla express stratified epithelial markers, 
although the thymus derives from endoderm and the skin derives 
from ectoderm. Recently, Bonfanti and colleagues demonstrated 
that a cultured population of TECs from rat thymus can integrate 
into a thymic epithelial network. These cells expressed major 
histocompatibility complex class II molecules and Aire. Most 
interestingly, these clonogenic TECs could function as epidermal 
stem cells and multipotent hair follicle stem cells upon expo-
sure to skin morphogenetic signals, and these TECs contributed 
to long-term epidermal renewal and hair follicle regeneration. 
These results suggest that skin determination is independent of 
primary germ line origin but dependent on microenvironmental 
cues. (Nature 466:978–82, 2010) Selected by R. Paus
Culpable IL-23
Recent evidence suggested that IL-23 is a key cytokine in 
psoriasis pathogenesis via its role in driving T helper type 17 
cell–mediated skin inflammation; however, whether this mol-
ecule is a useful therapeutic target remains unclear. Thus, 
Tonel and colleagues investigated this cytokine and its recep-
tor, IL-23R, in human psoriasis tissue samples and in a mouse 
xenograft psoriasis model. IL-23 was expressed in psoriatic 
skin samples, and IL-23R was expressed on psoriatic immune 
cells, including CD3+ T cells, CD8+ T cells, dermal dendritic 
cells, and epidermal Langerhans cells, as well as keratino-
cytes in the samples. In the mouse model, IL-23 production 
occurred later in the disease process and was correlated with 
the development of epithelial pathology. Injection of a human 
IL-23-specific monoclonal antibody significantly blocked the 
development of psoriasis in a clinically relevant mouse model. 
These results provide functional evidence for the role of IL-23 
in the pathogenesis of psoriasis and indicate that blockade 
of this pathway may serve as a useful therapeutic avenue for 
treatment of this chronic epithelial inflammatory disease. 
(J Immunol 185:5688–91, 2010) Selected by A. Blauvelt
Twist of fate
OCT4 expression during pluripotent reprogramming in human 
dermal fibroblasts (Fibs) results in the expression of lineage dif-
ferentiation markers, including the human pan-hematopoietic 
marker CD45. Although conversion of mouse fibroblasts to neu-
ral, cardiac, and macrophage-like cells has been reported, direct 
hematopoietic fate conversion from human fibroblasts has not 
yet been shown. Szabo and colleagues generated progenitors 
and mature cells of the myeloid, erythroid, and megakaryocytic 
lineages fate via OCT4-dependent programming in fibroblasts. 
These cells did not require passage through a pluripotent state or 
activation of mesodermal pathways to achieve this hematopoi-
etic differentiation. In addition, the CD45+ Fibs exhibited only 
limited engraftment potential in secondary recipient transplant 
mice, indicating that these cells do not possess leukemic stem 
cell properties. These results indicate that these cells may be use-
ful in autologous cell replacement therapies and may be safer 
hematopoietic transplantation product alternatives because 
human pluripotent stem cell–derived cells retain tumor potential. 
(Nature doi:10.1038/nature09591, 2010) Selected by T. Krieg
Immunological suppression in tumors
Therapeutic vaccination to a tumor-associated antigen that elic-
its a CD8+ T-cell response is rarely effective in controlling tumor 
growth, probably because of immune suppression within the 
tumor microenvironment. Recently, a tumoral stromal cell of 
mesenchymal origin was identified via expression of the fibro-
blast activation protein-α (FAP), and this cell type is involved 
in immune suppression in several biological processes. Thus, 
Kraman and colleagues assessed the immune suppressive 
function of FAP+ stromal cells in a tumoral microenvironment 
in transgenic mice. Ablation of FAP+ cells suppressed growth 
specifically in tumors that had induced an immune response. 
Furthermore, this FAP+ cell–induced growth suppression is 
mediated by tumor necrosis factor-α and IFN-γ, because the 
impairment was abolished with specific antibodies to these 
cytokines. These cytokines are known to be involved in CD8+ 
T cell–dependent cytotoxicity of antigen-loss variant tumor 
cells. Interference with immune suppression by FAP+ cells may 
enhance cancer immunotherapy strategies. (Science 330:827–
30, 2010) Selected by P. Bergstresser
Pervasive phenotype plasticity in melanoma
Heterogeneity between tumors as well as between cancer cells 
within the same tumor has spurred the notions of clonal evolu-
tion and the cancer stem cell model as explanations. Although 
these mechanisms are not mutually exclusive, the cancer stem 
cell model has been supported in several tumor models. In 
melanoma, however, Quintana and colleagues recently found 
that tumors do not exhibit a hierarchy of nontumorigenic and 
tumorigenic cells. Melanomas of stage II, III, or IV disease con-
sistently had high frequencies of tumorigenic cells, and the 
tumorigenic cells exhibited indefinite proliferation upon serial 
transplantation. In addition, no particular set of mole cular 
markers that specified tumorigenic cells could be identified 
because the tumorigenic capacity was not restricted to a small 
subpopulation of melanoma cells but was common to cell pop-
ulations that were phenotypically diverse. The tumorigenic cells 
also appeared to undergo reversible changes in the expression 
of many markers in vivo, supporting the idea that tumorigenic 
competence may be a reversible state in melanoma. (Cancer 
Cell 510–23, 2010) Selected by M. Herlyn
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